NEA 15 Amends Senti Biosciences Stake
Ticker: SNTI · Form: SC 13D/A · Filed: Dec 4, 2024 · CIK: 1854270
Sentiment: neutral
Topics: ownership-change, amendment, biotech
TL;DR
NEA 15 filed a 13D/A for Senti Biosciences, Inc. - ownership update.
AI Summary
New Enterprise Associates 15, L.P. (NEA 15) and its affiliated group members, including NEA 15 GP, LLC, Anthony A. Florence, Jr., Forest Baskett, and Mohamad H. Makhzoumi, have filed an amendment to their Schedule 13D on December 4, 2024, regarding Senti Biosciences, Inc. The filing indicates a change in their beneficial ownership of the company's securities.
Why It Matters
This amendment signals a potential shift in the investment strategy or holdings of a significant venture capital firm in a biotechnology company, which could influence market perception and future corporate actions.
Risk Assessment
Risk Level: medium — Changes in beneficial ownership filings can indicate shifts in investor sentiment or strategy, potentially impacting the stock price.
Key Players & Entities
- New Enterprise Associates 15, L.P. (company) — Filing entity
- NEA 15 GP, LLC (company) — Affiliated group member
- Anthony A. Florence, Jr. (person) — Affiliated group member
- Forest Baskett (person) — Affiliated group member
- Mohamad H. Makhzoumi (person) — Affiliated group member
- Senti Biosciences, Inc. (company) — Subject company
FAQ
What specific changes in beneficial ownership are detailed in this SC 13D/A filing?
The filing is an amendment to a Schedule 13D, indicating a change in the beneficial ownership of Senti Biosciences, Inc. securities by the group including New Enterprise Associates 15, L.P. Specific details of the change are not provided in the header information.
Who are the members of the group filing this amendment?
The group members listed are ANTHONY A. FLORENCE, JR., FOREST BASKETT, MOHAMAD H. MAKHZOUMI, NEA 15 GP, LLC, and NEA PARTNERS 15, L.P., with New Enterprise Associates 15, L.P. being the primary filer.
When was this amendment filed with the SEC?
This amendment was filed on December 4, 2024.
What is the subject company's primary business?
Senti Biosciences, Inc. is in the BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) industry, SIC code 2836.
What is the business address of Senti Biosciences, Inc.?
The business address is 2 CORPORATE DRIVE, FIRST FLOOR, SOUTH SAN FRANCISCO, CA 94080.
Filing Stats: 4,292 words · 17 min read · ~14 pages · Grade level 11.5 · Accepted 2024-12-04 19:08:03
Key Financial Figures
- $0.0001 — Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securiti
- $2.25 — ommon Stock, at the conversion price of $2.25 per share (the “Conversion Price&
- $2.30 — Each Warrant has an exercise price of $2.30 per share. The Warrants are exercisable
Filing Documents
- nea15_18913.htm (SC 13D/A) — 316KB
- 0001072613-24-000907.txt ( ) — 318KB
From the Filing
SC 13D/A 1 nea15_18913.htm NEW ENTERPRISE ASSOCIATES 15, L.P. / SENTI BIOSCIENCES, INC. -- SCHEDULE 13D/A(#1) Schedule 13D UNITED SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1)* Senti Biosciences, Inc. (Name of Issuer) Common Stock, $0.0001 par value (Title of Class of Securities) 81726A209 (CUSIP Number) Stephanie Brecher New Enterprise Associates 1954 Greenspring Drive, Suite 600 Timonium, MD 21093 (410) 842-4000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 2, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Note : Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See §240.13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.81726A209 13D Page 2 of 18 Pages 1 NAMES OF REPORTING PERSONS. New Enterprise Associates 15, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) WC 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 Shares 8 SHARED VOTING POWER 442,615 Shares 9 SOLE DISPOSITIVE POWER 0 Shares 10 SHARED DISPOSITIVE POWER 442,615 Shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 442,615 Shares 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.6% 14 TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.81726A209 13D Page 3 of 18 Pages 1 NAMES OF REPORTING PERSONS. NEA Partners 15, L.P. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) AF 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 Shares 8 SHARED VOTING POWER 442,615 Shares 9 SOLE DISPOSITIVE POWER 0 Shares 10 SHARED DISPOSITIVE POWER 442,615 Shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 442,615 Shares 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.6% 14 TYPE OF REPORTING PERSON (see instructions) PN CUSIP No.81726A209 13D Page 4 of 18 Pages 1 NAMES OF REPORTING PERSONS. NEA 15 GP, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) AF 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 0 Shares 8 SHARED VOTING POWER 442,615 Shares 9 SOLE DISPOSITIVE POWER 0 Shares 10 SHARED DISPOSITIVE POWER 442,615 Shares 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 442,615 Shares 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (see instructions) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 9.6% 14 TYPE OF REPORTING PERSON (see instructions) OO CUSIP No.81726A209 13D Page 5 of 18 Pages 1 NAMES OF REPORTING PERSONS. Forest Baskett 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (see instructions) (a) (b) 3 SEC USE ONLY 4 SOURCE OF FUNDS (see instructions) AF 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORG